National and Kapodistrian University of Athens
Η επίδραση της χορήγησης αντιπηκτικής αγωγής στην πνευμονική κυκλοφορία ασθενών με σήψη και ασθενών με οξεία πνευμονική βλάβη (ALI)
Abstract
dc:descriptionSevere sepsis and sepsis-related acute respiratory distress syndrome (ARDS), are associated with a major insult on endothelial anatomical and functional integrity that compromises microcirculation and leads to organ dysfunction. Treatment with recombinant human activated protein C (rhAPC) had been proved protective for the endothelial function, thus organ microcirculation. Until recently, it was given in accordance to the Surviving Sepsis Guidelines as a life-saving treatment in severely septic patients. The early recognition of endothelial dysfunction could contribute to the prompt therapeutic intervention of patients at high risk of developing organ dysfunction. Although various clinical scores and surrogate markers of endothelial dysfunction have been used, none has proved ideal for this purpose. Pulmonary Capillary Endothelium Bound (PCEB) Angiotensin Converting Enzyme (ACE) activity has been shown to be a direct and sensitive pulmonary endothelial dysfunction marker, in acute and chronic lung diseases. We present the results of a small cohort study in patients with septic ARDS where PCEB-ACE activity was tested as a marker of endothelial dysfunction, possibly useful as a diagnostic and prognostic index.We estimated PCEB-ACE activity in nineteen patients suffering from septic ARDS. Applying indicator-dilution type techniques, we measured single-pass transpulmonary percent metabolism (%M) and hydrolysis (v) of the synthetic, biologically inactive, and highly specific for ACE substrate 3H-benzoyl-Phe-Ala-Pro (BPAP), under first order reaction conditions, and calculated lung functional capillary surface area (FCSA) before, during and after treatment with rhAPC. Pulmonary endothelium ACE activity was severely impaired in patients with septic ARDS, but it was not affected by rhAPC treatment. Furthermore, more profound decrease in PCEB-ACE activity was related to poor outcome. ACE substrate utilization was significantly lower in non-survivors as compared to survivors (BPAP %M fluctuated from 32.7±3.4% at the baseline to 25.6±2.9% at day7 in survivors versus 20.8±2.8% to 15.5±5%, respectively in non survivors (p=0.044), while (v) fluctuated from 0.41±0.06 at baseline to 0.30±0.04 at day7 in survivors versus 0.24±0.04 to 0.18±0.06, respectively in non survivors (p=0.049). We conclude that PCEB-ACE activity indices could possibly be used as diagnostic means for the early recognition of endothelial dysfunction in septic patients necessitating immediate therapeutic intervention.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kaziani, Katerina
- Καζιάνη, Αικατερίνη
Subjects
dc:subject × 16- Βαρεία σήψη
- Οξύ σύνδρομο αναπνευστικής δυσχέρειας
- Ενεργοποιημένη πρωτεΐνη C
- Πολυοργανική ανεπάρκεια
- Αγγειομετατρεπτικό ένζυμο
- Ενδοθηλιακή δυσλειτουργία
- Severe sepsis
- ARDS
- Activated protein C
- Multiorgan dysfunction
- Endothelial dysfunction
- ACE
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39052